Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News N2OFF Inc NITO

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. The company’s products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on... see more

Current News (NDAQ:NITO)

N2OFF: MitoCareX Bio Spotlights Co-Founder's Pioneering Research on Mitochondrial Carriers in Spaceflight Stress Conditions

GlobeNewswire 4 days ago

N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake

GlobeNewswire January 5, 2026

N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy

GlobeNewswire December 29, 2025

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

GlobeNewswire November 18, 2025

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers

GlobeNewswire October 30, 2025

SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire October 23, 2025

N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire October 23, 2025

N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire October 8, 2025

N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire September 25, 2025

Opinion & Analysis (NDAQ:NITO)

No current opinion is available.

Bullboard Posts (NDAQ:NITO)

NITO/ SPRC....Merger NR

Both on watch in PM opening
Iseneschal - September 30, 2025

NITO...merger NR from 09/25

and post RS On watch....$4
Iseneschal - September 30, 2025

NITO.....day 2 of run

News this a.m ....volume & price action No position
Iseneschal - January 3, 2025

BUY BUY BUY BUY BUY

Multi bagger under your nose
Nibinator - July 31, 2024

SVFD...trade by trade reporting..... $2.50 now

What a game!!!!
Iseneschal - December 7, 2023

SVFD....LoL....$2.75 in AH trading

Told ya
Iseneschal - December 7, 2023

Podcasts